Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs
出版年份 2022 全文链接
标题
Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs
作者
关键词
-
出版物
Pathogens
Volume 11, Issue 11, Pages 1259
出版商
MDPI AG
发表日期
2022-10-30
DOI
10.3390/pathogens11111259
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice
- (2022) Baoling Ying et al. CELL
- The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates
- (2022) Greta Volpedo et al. Pathogens
- Global distribution of treatment resistance gene markers for leishmaniasis
- (2022) Samira Salari et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases
- (2022) Hui-Lee Wong et al. LANCET
- Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study
- (2022) Marco Massari et al. PLOS MEDICINE
- Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates
- (2022) Sakshi Mohan et al. PLoS Neglected Tropical Diseases
- Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge
- (2022) Shanna S. Leventhal et al. EBioMedicine
- Myocarditis or Pericarditis Following the COVID-19 Vaccination in Adolescents: A Systematic Review
- (2022) Minglong Li et al. Vaccines
- Memory CD8+ T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination
- (2022) Nadia Brasu et al. NATURE IMMUNOLOGY
- T cell immunity to COVID-19 vaccines
- (2022) E. John Wherry et al. SCIENCE
- Characterization of a new Leishmania major strain for use in a controlled human infection model
- (2021) Helen Ashwin et al. Nature Communications
- Leishmania eukaryotic elongation Factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection
- (2021) Thaís T.O. Santos et al. MICROBIAL PATHOGENESIS
- An Update on Self-Amplifying mRNA Vaccine Development
- (2021) Anna K. Blakney et al. Vaccines
- Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan
- (2021) Brima M. Younis et al. MOLECULAR THERAPY
- Intranasal immunization with chitosan microparticles enhances lack-dna vaccine protection and induces specific long-lasting immunity against visceral leishmaniasis
- (2021) Daniel Claudio Oliveira Gomes et al. MICROBES AND INFECTION
- The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach
- (2021) Matthew Greenhawt et al. Journal of Allergy and Clinical Immunology-In Practice
- Overcoming roadblocks in the development of vaccines for leishmaniasis
- (2021) Paul M. Kaye et al. Expert Review of Vaccines
- Vaccines against leishmaniasis: using controlled human infection models to accelerate development
- (2021) Vivak Parkash et al. Expert Review of Vaccines
- Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8High T Cells Are Associated With the Cure of Human Visceral Leishmaniasis
- (2021) Lorranny Santana Rodrigues et al. Frontiers in Immunology
- A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics
- (2020) Marijke C. C. Langenberg et al. NATURE MEDICINE
- Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure
- (2020) Nir Eyal et al. JOURNAL OF INFECTIOUS DISEASES
- Ethics of controlled human infection to address COVID-19
- (2020) Seema K. Shah et al. SCIENCE
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates
- (2020) Jesse H. Erasmus et al. Science Translational Medicine
- A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing
- (2020) Wen-Wei Zhang et al. Nature Communications
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- “Running the Gauntlet”: Formidable challenges in advancing neglected tropical diseases vaccines from development through licensure, and a “Call to Action”
- (2019) Maria Elena Bottazzi et al. Human Vaccines & Immunotherapeutics
- How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella?
- (2019) Birgitte K. Giersing et al. VACCINE
- Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections
- (2019) Leroy Versteeg et al. Vaccines
- Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis
- (2019) Beatriz Coutinho De Oliveira et al. Human Vaccines & Immunotherapeutics
- Experimental infection of human volunteers
- (2018) Meta Roestenberg et al. LANCET INFECTIOUS DISEASES
- Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
- (2018) Annette B. Vogel et al. MOLECULAR THERAPY
- Therapeutic vaccine of killed Leishmania amazonensis plus saponin reduced parasite burden in dogs naturally infected with Leishmania infantum
- (2018) Kelvinson Fernandes Viana et al. VETERINARY PARASITOLOGY
- Randomized, controlled, double-blinded field trial to assess Leishmania vaccine effectiveness as immunotherapy for canine leishmaniosis
- (2018) Angela Toepp et al. VACCINE
- Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani
- (2018) Malcolm S. Duthie et al. Frontiers in Immunology
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- Plasmodium vivax Controlled Human Malaria Infection – Progress and Prospects
- (2017) Ruth O. Payne et al. TRENDS IN PARASITOLOGY
- A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
- (2017) Mohamed Osman et al. PLoS Neglected Tropical Diseases
- Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre
- (2017) Victoria M. W. Gould et al. Frontiers in Microbiology
- A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden
- (2017) Bruno Mendes Roatt et al. Frontiers in Immunology
- A defined subunit vaccine that protects against vector-borne visceral leishmaniasis
- (2017) Malcolm S. Duthie et al. npj Vaccines
- The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model
- (2016) Beth D. Kirkpatrick et al. Science Translational Medicine
- Recovery of antigen-specific T cell responses from dogs infected with Leishmania ( L .) infantum by use of vaccine associated TLR-agonist adjuvant
- (2016) Robert G. Schaut et al. VACCINE
- Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin
- (2015) Michela Brazzoli et al. JOURNAL OF VIROLOGY
- Role of CD8+ T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals
- (2014) Himanshu Kaushal et al. BMC INFECTIOUS DISEASES
- Self-replicating alphavirus RNA vaccines
- (2014) Karl Ljungberg et al. Expert Review of Vaccines
- Programmed Death 1-Mediated T Cell Exhaustion during Visceral Leishmaniasis Impairs Phagocyte Function
- (2013) K. J. Esch et al. JOURNAL OF IMMUNOLOGY
- CD8 T Cell Exhaustion in Human Visceral Leishmaniasis
- (2013) Shalini Gautam et al. JOURNAL OF INFECTIOUS DISEASES
- Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice
- (2013) Armin Hekele et al. Emerging Microbes & Infections
- Pseudoinfectious Venezuelan Equine Encephalitis Virus: a New Means of Alphavirus Attenuation
- (2012) S. Atasheva et al. JOURNAL OF VIROLOGY
- ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans
- (2012) Susanne H Sheehy et al. MOLECULAR THERAPY
- T Helper1/T Helper2 Cells and Resistance/Susceptibility to Leishmania Infection: Is This Paradigm Still Relevant?
- (2012) James Alexander et al. Frontiers in Immunology
- Developments in the treatment of visceral leishmaniasis
- (2009) Margriet Leontine den Boer et al. EXPERT OPINION ON EMERGING DRUGS
- Optimized subunit vaccine protects against experimental leishmaniasis
- (2009) Sylvie Bertholet et al. VACCINE
- Nonviral Vectors for Gene Delivery
- (2008) Meredith A. Mintzer et al. CHEMICAL REVIEWS
- Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis
- (2008) Shraddha Kumari et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now